As the ovarian tumour cells are known to excrete the endothelial growth factor VEGF-A as well, this suggests an autocrine/paracrine growth factor function of VEGF-A in ovarian cancer through the AKT/mTOR signalling pathway. The gene discussed is AKT1; the disease is ovarian neoplasm.